Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture Administered to Adult and Elderly Subjects
Clinical trial NCT01422512 · COMPLETED
Trial details
- NCT number
- NCT01422512
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2011-10-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.